FUSIBEC

FUSIBEC Cream is contraindicated in patients with known hypersensitivity to fusidic acid, beclomethasone dipropionate, chlorocresol, or any components of the cream base. It must not be applied to untreated primary cutaneous viral infections (e.g., herpes simplex, chickenpox), fungal skin infections, cutaneous tuberculosis, syphilitic skin lesions, perioral dermatitis, rosacea, or open skin ulcers.

Avoid contact with the eyes, nose, mouth, and open deep wounds to prevent systemic mucosal irritation. Do not apply under tight occlusive dressings or bandages unless directed by a doctor, as occlusion dramatically increases systemic steroid absorption and the risk of hypothalamic-pituitary-adrenal (HPA) axis suppression. If severe local irritation develops or the clinical infection does not demonstrate improvement within 7 days, discontinue use and evaluate alternative therapies. Use with caution during pregnancy or lactation, ensuring it is not applied over large surface areas or the breasts.

As a topical preparation, systemic interactions are minimal. Concomitant application of other topical corticosteroids or skin products at the exact same site should be avoided. Maintain a minimum gap of 2 to 3 hours between different topical agents to avoid cross-dilution or altered therapeutic efficacy.

Store below 25°C in a dry place. Protect from freezing and direct sunlight. Keep the tube tightly closed when not in use. Keep out of reach of children.